US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by ImageneBio, Inc.

News headline image
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio Reports Second Quarter 2026 Financial Results
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio Appoints Matt Robbins as General Counsel
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio Announces $30 Million Private Placement
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio to Participate in Leerink Global Healthcare Conference
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA MLTX
News headline image
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA
News headline image
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
From ImageneBio, Inc.
Via GlobeNewswire
Tickers IMA